Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 12/2010

01-12-2010 | Brief Report

Stronger correlation between antibiotic use and the incidence of Clostridium difficile determined by culture results instead of faecal toxin detection only

Authors: D. Mertz, R. Frei, H. Plagge, M. Battegay, A. F. Widmer

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 12/2010

Login to get access

Abstract

The detection of Clostridium difficile in previous studies evaluating antibiotic use as a risk factor was limited to toxin assay tests. The reported associations may have been misleading due to the low sensitivity of toxin assay tests compared to culture results. Antibiotic use and the incidence of C. difficile of 19 units (wards) over 5 years were analysed. Stool samples were tested for toxin A/B and cultured. The correlation of antibiotic use with the incidence of C. difficile determined by culture results was compared to the correlation determined by toxin assay results. Additionally, single antibiotics were analysed as risk factors. Of 5,772 faecal samples tested for C. difficile, 154 single-first cases were detected by the toxin assay and 251 additional single-first cases by culture. Antibiotic use was a significantly stronger risk factor in the correlation based on the culture results (R 2 = 0.63) versus toxin assay results (R 2 = 0.40). Multivariate analysis did not improve the correlation significantly and only the group of broad-spectrum beta-lactams was identified as an independent risk factor. The correlation between antibiotic use and C. difficile incidence rates significantly improves if detection is not limited to faecal toxin assays. Therefore, antibiotic pressure was previously underestimated as a risk factor.
Literature
1.
go back to reference McFarland LV (2008) Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 5(1):40–48CrossRefPubMed McFarland LV (2008) Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 5(1):40–48CrossRefPubMed
2.
go back to reference Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Funston C, Savage K, Kelly D, Aldiab MA, McElnay JC (2009) Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother 53(5):2082–2088CrossRefPubMed Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Funston C, Savage K, Kelly D, Aldiab MA, McElnay JC (2009) Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother 53(5):2082–2088CrossRefPubMed
3.
go back to reference Thomas C, Stevenson M, Riley TV (2003) Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 51(6):1339–1350CrossRefPubMed Thomas C, Stevenson M, Riley TV (2003) Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 51(6):1339–1350CrossRefPubMed
4.
go back to reference Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, Bonnabry P, Davey P (2009) Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother 63(6):1272–1275CrossRefPubMed Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, Bonnabry P, Davey P (2009) Temporal effects of antibiotic use and Clostridium difficile infections. J Antimicrob Chemother 63(6):1272–1275CrossRefPubMed
5.
go back to reference Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S19–S31CrossRefPubMed Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S19–S31CrossRefPubMed
6.
go back to reference Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41(9):1254–1260CrossRefPubMed Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41(9):1254–1260CrossRefPubMed
7.
go back to reference Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pépin J, Wilcox MH, Society for Healthcare Epidemiology of America; Infectious Diseases Society of America (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431–455CrossRefPubMed Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pépin J, Wilcox MH, Society for Healthcare Epidemiology of America; Infectious Diseases Society of America (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 31(5):431–455CrossRefPubMed
8.
go back to reference Fenner L, Widmer AF, Goy G, Rudin S, Frei R (2008) Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46(1):328–330CrossRefPubMed Fenner L, Widmer AF, Goy G, Rudin S, Frei R (2008) Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46(1):328–330CrossRefPubMed
9.
go back to reference Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15(12):1053–1066CrossRefPubMed Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ (2009) European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15(12):1053–1066CrossRefPubMed
10.
go back to reference Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S (2008) Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 62(3):601–607CrossRefPubMed Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S (2008) Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother 62(3):601–607CrossRefPubMed
Metadata
Title
Stronger correlation between antibiotic use and the incidence of Clostridium difficile determined by culture results instead of faecal toxin detection only
Authors
D. Mertz
R. Frei
H. Plagge
M. Battegay
A. F. Widmer
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 12/2010
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-1022-z

Other articles of this Issue 12/2010

European Journal of Clinical Microbiology & Infectious Diseases 12/2010 Go to the issue